Nicotinic Cholinergic Receptor Binding Sites in the Brain: Regulation in Vivo
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Tritiated acetylcholine was used to measure binding sites with characteristics of nicotinic cholinergic receptors in rat brain. Regulation of the binding sites in vivo was examined by administering two drugs that stimulate nicotinic receptors directly or indirectly. After 10 days of exposure to the cholinesterase inhibitor diisopropyl fluorophosphate, binding of tritiated acetylcholine in the cerebral cortex was decreased. However, after repeated administration of nicotine for 10 days, binding of tritiated acetylcholine in the cortex was increased. Saturation analysis of tritiated acetylcholine binding in the cortices of rats treated with diisopropyl fluorophosphate or nicotine indicated that the number of binding sites decreased and increased, respectively, while the affinity of the sites was unaltered.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been shown that high-dose chronic and intermittent nicotine exposure increases levels of high-affinity nicotinic receptors in adult humans and rodents (10–14).”
In the citing paper
“Repeated or prolonged nicotine exposure increases the number of high-affinity (mainly α4β2*) nicotine-binding sites, in heterologous systems (41, 42), nicotine-treated animals (11, 12), and in post mortem brains of smokers (ref. 10; for review, see ref. 43).”
In the citing paper
“animals exposed to nicotine chronically exhibit increased levels of nAChRs in the brain (Marks et al., 1983(Marks et al., , 1985(Marks et al., , 1992;;Schwartz and Kellar, 1983)”
From Human Tobacco Smokers in Early Abstinence Have Higher Levels of β2* Nicotinic Acetylcholine Receptors than Nonsmokers (2006) · cites this paper as Schwartz and Kellar, 1983
In the citing paper
“A hallmark of chronic nicotine administration is the upregulation of nicotinic receptors in the brain (Marks et al, 1983; Schwartz and Kellar, 1983) and recent studies in humans have suggested a functional role of these receptors in relapse vulnerability (Cosgrove et al, 2009).”
From Divergent Functional Effects of Sazetidine-A and Varenicline During Nicotine Withdrawal (2013) · cites this paper as Schwartz and Kellar, 1983
In the citing paper
“Chronic nicotine administration increases ␣42 neuronal nicotinic acetylcholine receptor (nAChR) density in brain.”
From Chronic Sazetidine-A at Behaviorally Active Doses Does Not Increase Nicotinic Cholinergic Receptors in Rodent Brain (2012) · cites this paper as Schwartz and Kellar, 1983
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A new and rapid colorimetric determination of acetylcholinesterase activity
Ellman, G. L., Courtney, K. D., Andres, V., & Featherstone, R. M. (1961) · Biochemical Pharmacology · doi:10.1016/0006-2952(61)90145-9 · Cited by 27,126
Muscarinic Cholinergic Binding in Rat Brain
Yamamura, H. I., & Snyder, S. H. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.5.1725 · Cited by 1,203
Annual Review of Pharmacology,
Williams, J. F. (1975) · Archives of Internal Medicine · doi:10.1001/archinte.1975.00330100136032 · Cited by 386
Stereospecific Nicotine Receptors on Rat Brain Membranes
Romano, C., & Goldstein, A. (1980) · Science · doi:10.1126/science.7433991 · Cited by 319
Receptor Adaptations to Centrally Acting Drugs
Creese, I., & Sibley, D. R. (1981) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.21.040181.002041 · Cited by 290
THESLEFF, S. (1955) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1955.tb01242.x · Cited by 281
Nicotinic cholinergic receptors labeled by [3H]acetylcholine in rat brain.
Schwartz, R. D., McGee, R., & Kellar, K. J. (1982) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15102-x · Cited by 261
Self-citationNicotine-induced antinociception in rats and mice: correlation with nicotine brain levels.
Tripathi, H. L., Martin, B. R., & Aceto, M. D. (1982) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33022-3 · Cited by 171
The action potential of the superior cervical ganglion
Eccles, J. C. (1935) · The Journal of Physiology · doi:10.1113/jphysiol.1935.sp003313 · Cited by 165
Regulation of neocortical muscarinic receptors: effects of drug treatment and lesions
McKinney, M., & Coyle, J. (1982) · Journal of Neuroscience · doi:10.1523/jneurosci.02-01-00097.1982 · Cited by 156
Research works printed but not linked: 2
- DALE, H.H., J PHARMACOL EXP THER 6: 174 (1914).
- PORSIUS, A. J., ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH 28: 1628 (1978).
Cited by
Nicotinic acetylcholine involvement in cognitive function in animals
Levin, E. D., & Simon, B. B. (1998) · Psychopharmacology · doi:10.1007/s002130050667 · Cited by 678
Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment
Marks, M., Pauly, Jr., Gross, S., Deneris, E., Hermans-Borgmeyer, I., Heinemann, S., & Collins, A. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-07-02765.1992 · Cited by 551
“, 1983), rats (Schwartz and Kellar, 1983) and humans (Benwell et al.”
BackgroundInfluentialEvidence that Tobacco Smoking Increases the Density of (−)‐[3H]Nicotine Binding Sites in Human Brain
Benwell, M. E. M., Balfour, D. J. K., & Anderson, J. M. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb10600.x · Cited by 551
Nicotinic acetylcholine receptors: From basic science to therapeutics
Hurst, R., Rollema, H., & Bertrand, D. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.012 · Cited by 522
Nicotinic systems and cognitive function
Levin, E. D. (1992) · Psychopharmacology · doi:10.1007/bf02247415 · Cited by 514
Nicotinic acetylcholine binding sites in Alzheimer's disease
Whitehouse, P. J., Martino, A. M., Antuono, P. G., Lowenstein, P. R., Coyle, J. T., Price, D. L., & Kellar, K. J. (1986) · Brain Research · doi:10.1016/0006-8993(86)90819-x · Cited by 486
Self-citationNicotinic acetylcholine receptors in health and disease
Lindstrom, J. (1997) · Molecular Neurobiology · doi:10.1007/bf02740634 · Cited by 449
“Chronic exposure to agonists can also induce upregulation in the amount of various AChR subtypes to various degrees (Schwartz and Kellar, 1983; Benwell et al., 1988; Flores et al., 1992; Marks et al., 1992; Peng et al., 1994, 1997).”
BackgroundEffects of nicotinic stimulation on cognitive performance
Newhouse, P. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.11.001 · Cited by 405
Effect of smoking history on [3H]nicotine binding in human postmortem brain
Breese, C. R., Marks, M. J., Logel, J., Adams, C. E., Sullivan, B., Collins, A. C., & Leonard, S. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36798-9 · Cited by 396
Neuronal Nicotinic Acetylcholine Receptors
Lindstrom, J. (1996) · Ion Channels · doi:10.1007/978-1-4899-1775-1_10 · Cited by 382
Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue?
Morens, D. M., Grandinetti, A., Reed, D., White, L. R., & Ross, G. W. (1995) · Neurology · doi:10.1212/wnl.45.6.1041 · Cited by 370
Reward, addiction, withdrawal to nicotine
De Biasi, M., & Dani, J. A. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113734 · Cited by 366
“…nicotine use is the subtype-specific upregulation of nAChRs (Buisson & Bertrand 2001; Changeux et al. 1984; Dani & Heinemann 1996; Flores et al. 1997; Mansvelder et al. 2002; Marks et al. 1983, 1992; Perry et al. 1999; Rezvani et al. 2007, 2009; Rowell & Wonnacott 1990; Schwartz & Kellar 1983).”
BackgroundIncreased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies
Perry, D. C., Dávila-Garcı́a, M. I., Stockmeier, C. A., & Kellar, K. J. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38304-1 · Cited by 362
“…of these receptors, nicotine may exert widespread influences on the function of several important neural pathways in the CNS. Chronic administration of nicotine increases the density of nicotinic receptor binding sites in rat and mouse brain (Schwartz and Kellar, 1983; Marks et al., 1983).”
Self-citationGrady, S., Marks, M. J., Wonnacott, S., & Collins, A. C. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08322.x · Cited by 350
Govind, A. P., Vezina, P., & Green, W. N. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.011 · Cited by 338
“First measurements of upregulation were made with 3H acetylcholine (ACh) [96] as well as with (3)H-nicotine [95] followed by (3)Hcytisine [111] and then with radio-labeled epibatidine [112] which can be tritiated [11] or (125)I-iodinated [113].”
BackgroundMethodEffects of Abstinence from Tobacco: A Critical Review
Hughes, J. R., Higgins, S. T., & Hatsukami, D. (1990) · Research Advances in Alcohol and Drug Problems · doi:10.1007/978-1-4899-1669-3_10 · Cited by 311
Flynn, D. D., & Mash, D. C. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb13113.x · Cited by 285
In Vivo Regulation of [3H]Acetylcholine Recognition Sites in Brain by Nicotinic Cholinergic Drugs
Schwartz, R. D., & Kellar, K. J. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb04005.x · Cited by 285
Self-citationNashmi, R., Xiao, C., Deshpande, P., McKinney, S., Grady, S. R., Whiteaker, P., Huang, Q., McClure-Begley, T., Lindstrom, J. M., Labarca, C., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2199-07.2007 · Cited by 274
“DOI:10.1523/JNEUROSCI.2199-07.2007 Copyright © 2007 Society for Neuroscience 0270-6474/07/278202-17$15.00/0 gions for the same subtype (Marks et al., 1983, 2004; Schwartz and Kellar, 1983; Pauly et al., 1996; Nguyen et al., 2004; McCallum et al., 2006).”
BackgroundInfluentialNeurobiology of nicotine dependence
Markou, A. (2008) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0095 · Cited by 268
“…leads to an interesting paradoxical change in the function of nAChRs, which consists of receptor desensitization leading to receptor upregulation (Marks et al. 1983; Schwartz & Kellar 1983; Changeux et al. 1984; Wonnacott 1990; Flores et al. 1997; Perry et al. 1999; Mansvelder et al. 2002).”
BackgroundDonny, E. C., Caggiula, A. R., Rowell, P. P., Gharib, M. A., Maldovan, V., Booth, S., Mielke, M. M., Hoffman, A., & McCallum, S. (2000) · Psychopharmacology · doi:10.1007/s002130000497 · Cited by 266
Prenatal adverse effects of nicotine on the developing brain
(1988) · Progress in Brain Research · doi:10.1016/s0079-6123(08)60502-6 · Cited by 265
Nicotine upregulates its own receptors through enhanced intracellular maturation
Sallette, J., Pons, S., Devillers-Thiery, A., Soudant, M., Prado de Carvalho, L., Changeux, J.-P., & Corringer, P. J. (2005) · Neuron · doi:10.1016/j.neuron.2005.03.029 · Cited by 261
Neuronal nicotinic receptors: Molecular organization and regulations
Galzi, J.-L., & Changeux, J.-P. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00034-4 · Cited by 260
Salas, R., Pieri, F., & De Biasi, M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1939-04.2004 · Cited by 226
“As expected, epibatidine binding was increased during nicotine treat- ment in control mice (Marks et al., 1983; Schwartz and Kellar, 1983).”
BackgroundNicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol
Söderpalm, B., Ericson, M., Olausson, P., Blomqvist, O., & Engel, J. A. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00203-5 · Cited by 230
Staley, J. K., Krishnan-Sarin, S., Cosgrove, K. P., Krantzler, E., Frohlich, E., Perry, E., Dubin, J. A., Estok, K., Brenner, E., Baldwin, R. M., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0546-06.2006 · Cited by 229
“…that numbers of nAChRs are higher in smokers than in nonsmokers or former smokers (Benwell et al., 1988; Breese et al., 1997; Perry et al., 1999), and animals exposed to nicotine chronically exhibit increased levels of nAChRs in the brain (Marks et al., 1983, 1985, 1992; Schwartz and Kellar, 1983).”
BackgroundNeural Systems Governed by Nicotinic Acetylcholine Receptors: Emerging Hypotheses
Miwa, J. M., Freedman, R., & Lester, H. A. (2011) · Neuron · doi:10.1016/j.neuron.2011.03.014 · Cited by 205
Ksir, C., Hakan, R., Hall, D. P., & Kellar, K. J. (1985) · Neuropharmacology · doi:10.1016/0028-3908(85)90058-9 · Cited by 204
Self-citationNicotine patches in Alzheimer's disease: Pilot study on learning, memory, and safety
Wilson, A. L., Langley, L. K., Monley, J., Bauer, T., Rottunda, S., McFalls, E., Kovera, C., & McCarten, J. R. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00043-v · Cited by 197
α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson’s Disease
Quik, M., & Wonnacott, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003269 · Cited by 192
Balfour, D. J. K., & Fagerström, K. O. (1996) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00099-x · Cited by 195
Sparks, J. A., & Pauly, J. R. (1999) · Psychopharmacology · doi:10.1007/s002130050818 · Cited by 188
“Chronic nicotine exposure is also known to cause an increase in the density of neuronal nicotinic receptor (nAChr) subtypes (Marks et al. 1983; Schwartz and Kellar 1983; Ksir et al. 1985; Wonnacott, 1990; Pauly et al. 1991, 1996; Sanderson et al. 1993; Schwartz and Kellar 1985).”
BackgroundWang, J. C., Cruchaga, C., Saccone, N. L., Bertelsen, S., Liu, P., Budde, J. P., Duan, W., Fox, L., Grucza, R. A., Kern, J., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp231 · Cited by 188
Pharmacology of Neuronal Nicotinic Acetylcholine Receptor Subtypes
Colquhoun, L. M., & Patrick, J. W. (1997) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60072-1 · Cited by 180
Central nicotinic receptors, neurotrophic factors and neuroprotection
Belluardo, N., Mudò, G., Blum, M., & Fuxe, K. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00197-2 · Cited by 176
Navarro, H. A., Seidler, F. J., Schwartz, R. D., Baker, F. E., Dobbins, S. S., & Slotkin, T. A. (1989) · Brain Research Bulletin · doi:10.1016/0361-9230(89)90146-9 · Cited by 171
Self-citationBrain Regional Heterogeneity and Toxicological Mechanisms of Organophosphates and Carbamates
Gupta, R. C. (2004) · Toxicology Mechanisms and Methods · doi:10.1080/15376520490429175 · Cited by 169
“Schwartz and Keller (1983) reported a decreased binding of [3H]-ACh (23”
BackgroundSrinivasan, R., Pantoja, R., Moss, F. J., Mackey, E. D. W., Son, C. D., Miwa, J., & Lester, H. A. (2011) · Journal of General Physiology · doi:10.1085/jgp.201010532 · Cited by 169
Bergen, A. W., & Caporaso, N. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.16.1365 · Cited by 158
Lester, H. A., Xiao, C., Srinivasan, R., Son, C. D., Miwa, J., Pantoja, R., Banghart, M. R., Dougherty, D. A., Goate, A. M., & Wang, J. C. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9090-7 · Cited by 163
Nicotine, Brain Nicotinic Receptors, and Neuropsychiatric Disorders
Mihailescu, S., & Drucker-Colı́n, R. (2000) · Archives of Medical Research · doi:10.1016/s0188-4409(99)00087-9 · Cited by 162
Cosgrove, K. P., Batis, J., Bois, F., Maciejewski, P. K., Esterlis, I., Kloczynski, T., Stiklus, S., Krishnan-Sarin, S., O’Malley, S., Perry, E., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.41 · Cited by 165
Brain α7 Nicotinic Acetylcholine Receptor Assembly Requires NACHO
Gu, S., Matta, J. A., Lord, B., Harrington, A., Sutton, S. W., Davini, W. B., & Bredt, D. S. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.018 · Cited by 175
Brown, R. W., & Kolb, B. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02201-6 · Cited by 156
Mechanisms underlying sensitivity to organophosphorus anticholinesterase compounds
Russell, R. W., & Overstreet, D. H. (1987) · Progress in Neurobiology · doi:10.1016/0301-0082(87)90008-6 · Cited by 152
Nguyen, H. N., Rasmussen, B. A., & Perry, D. C. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.056408 · Cited by 148
“Up-regulation of 4 2 nAChR following chronic exposure to nicotine in rodents was first observed 20 years ago (Marks et al., 1983; Schwartz and Kellar, 1983).”
BackgroundXiao, Y., & Kellar, K. J. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.066787 · Cited by 148
“Exposure to nicotine increases the number of nAChRs in rodent and human brain in vivo (Marks et al., 1983; Schwartz and Kellar, 1983; Benwell et al., 1988; Breese et al., 1997; Perry et al., 1999) and in mammalian cell lines that express native (Peng et al., 1997; Avila et al., 2003) or…”
BackgroundSelf-citationMechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
“Similar increases were subsequently reproduced in the brains of mice and rats after repeated nicotine administration (Marks et al., 1983; Schwartz and Kellar, 1983; Yates et al., 1995; Pietila et al., 1998).”
BackgroundChronic nicotine and locomotor activity: influences of exposure dose and test dose
Ksir, C. J., Hakan, R. L., & Kellar, K. J. (1987) · Psychopharmacology · doi:10.1007/bf00215474 · Cited by 155
Self-citationFeduccia, A. A., Chatterjee, S., & Bartlett, S. E. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00083 · Cited by 162
“, 1999) and nicotine-treated rodents (Schwartz and Kellar, 1983; Flores et al., 1992; Marks et al., 1992; Gentry and Lukas, 2002).”
BackgroundFlores, C. M., Dávila‐García, M. I., Ulrich‐Lai, Y. M., & Kellar, K. J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69052216.x · Cited by 151
“Although it has been suggested that receptor inactivation may be a requisite signal leading to receptor up-regulation (Marks et al., 1983, 1985; Schwartz and Kellar, 1983, 1985), it is not known whichreceptor subtypes undergo desensitization and inactivation in vivo, or which develop tolerance to…”
BackgroundSelf-citationXiao, Y., Fan, H., Musachio, J. L., Wei, Z.-L., Chellappan, S. K., Kozikowski, A. P., & Kellar, K. J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027318 · Cited by 141
“In addition to these two immediate effects, long-term exposure to nicotine or other agonists increases the density of nAChRs in brain (Marks et al., 1983; Schwartz and Kellar, 1983).”
BackgroundSelf-citationResponse of the hypothalamo-pituitary-adrenal axis to nicotine
Matta, S. G., Fu, Y., Valentine, J. D., & Sharp, B. M. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00079-6 · Cited by 153
Chronic oral nicotine treatment protects against striatal degeneration in MPTP‐treated primates
Quik, M., Parameswaran, N., McCallum, S. E., Bordia, T., Bao, S., McCormack, A. L., Kim, A., Tyndale, R. F., Langston, J. W., & Monte, D. A. D. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04078.x · Cited by 151
“An increase in nicotinic receptors was observed in caudate and putamen of unlesioned primates after nicotine treatment (Figs 1c and d), consistent with previous studies in rodents (Marks et al. 1983; Schwartz and Kellar 1983; Gentry and Lukas 2002).”
ResultSunderland, T., Tariot, P. N., & NEWHOUSE, P. A. (1988) · Brain Research · doi:10.1016/0006-8993(88)91227-9 · Cited by 138
Mao, D., Perry, D. C., Yasuda, R. P., Wolfe, B. B., & Kellar, K. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05011.x · Cited by 133
Self-citationChronic nicotine and withdrawal effects on radial-arm maze performance in rats
Levin, E. D., Lee, C. K., Rose, J. E., Reyes, A., Ellison, G. D., Jarvik, M. E., & Gritz, E. R. (1990) · Behavioral and Neural Biology · doi:10.1016/0163-1047(90)90509-5 · Cited by 132
Levin, E. D., & Rezvani, A. H. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.019 · Cited by 129
Cholinotoxic Effects of Aluminum in Rat Brain
Gulya, K., Rakonczay, Z., & Kása, P. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02352.x · Cited by 124
Sex Differences in Nicotine Action
Pöğün, Ş., & Yararbaş, G. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_10 · Cited by 130
Tolerance to and cross tolerance between ethanol and nicotine
Collins, A. C., Burch, J. B., de Fiebre, C. M., & Marks, M. J. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90170-0 · Cited by 124
Early developmental changes in [3H]nicotine binding in the human brainstem
Kinney, H. C., O'Donnell, T. J., Kriger, P., & White, W. F. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90326-b · Cited by 127
D’Souza, M. S., & Markou, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.044 · Cited by 129
“Finally, preclinical studies have shown that repeated administration of nicotine upregulates nAChRs (Flores et al., 1992; Schwartz and Kellar, 1983; Yates et al., 1995).”
Araujo, D. M., Lapchak, P. A., Collier, B., & Quirion, R. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb04869.x · Cited by 121
Crooks, P. A., & Dwoskin, L. P. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00117-2 · Cited by 135
Aggarwal, N. T., Bienias, J. L., Bennett, D. A., Wilson, R. S., Morris, M. C., Schneider, J. A., Shah, R. C., & Evans, D. A. (2006) · Neuroepidemiology · doi:10.1159/000091654 · Cited by 137
Govind, A. P., Walsh, H., & Green, W. N. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5438-11.2012 · Cited by 129
“Upregulation occurs when nicotine exposure increases highaffinity nicotine-binding sites in brain, measured by radiolabeled agonists such as nicotine (Marks et al., 1983; Schwartz and Kellar, 1983; Benwell et al., 1988; Breese et al., 1997) or epibatidine (Perry et al., 1999).”
BackgroundMiksys, S. L., Hoffmann, E. B., & Tyndale, R. F. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00281-1 · Cited by 134
Lapchak, P. A., Araujo, D. M., Quirion, R., & Collier, B. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09146.x · Cited by 113
Molecular and Cellular Mechanisms of Action of Nicotine in the CNS
Barik, J., & Wonnacott, S. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_7 · Cited by 123
Nybäck, H., Halldin, C., Åhlin, A., Curvall, M., & Eriksson, L. I. (1994) · Psychopharmacology · doi:10.1007/bf02244748 · Cited by 110
Perry, D. C., Mao, D., Gold, A. B., McIntosh, J. M., Pezzullo, J. C., & Kellar, K. J. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121228 · Cited by 106
“Chronic exposure to nicotine increases nAChR binding sites in post mortem brains from rats (Schwartz and Kellar, 1983), mice (Marks et al.”
BackgroundSelf-citationCosgrove, K., Esterlis, I., McKee, S. A., Bois, F., Seibyl, J. P., Mazure, C. M., Krishnan‐Sarin, S., Staley, J. K., Picciotto, M. R., & O'Malley, S. S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1465 · Cited by 113
Parker, S. L., Fu, Y., McAllen, K., Luo, J., McIntosh, J. M., Lindstrom, J. M., & Sharp, B. M. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.611 · Cited by 117
“, 1996) and rats (Schwartz and Kellar, 1983; Mugnaini et al., 2002); as well as in mammalian cells expressing cloned nAChRs (Wang et al.”
BackgroundResultPrenatal nicotine alters nicotinic receptor development in the mouse brain
van de Kamp, J. L., & Collins, A. C. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90293-3 · Cited by 110
Inside-out neuropharmacology of nicotinic drugs
Henderson, B. J., & Lester, H. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.022 · Cited by 119
“In 1983, it was discovered that chronic exposure to nicotine leads to an increased binding of nicotine at neuronal nicotinic acetylcholine receptors (AChRs) (Breese et al., 1997; Mamede et al., 2007; Marks et al., 1983; Nashmi et al., 2007; Schwartz and Kellar, 1983).”
Nicotine psychopharmacology: Addiction, cognition and neuroadaptation
Stolerman, I. P., Mirza, N. R., & Shoaib, M. (1995) · Medicinal Research Reviews · doi:10.1002/med.2610150105 · Cited by 111
Postnatal Development of Cholinergic Enzymes and Receptors in Mouse Brain
Fiedler, E. P., Marks, M. J., & Collins, A. C. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb00990.x · Cited by 101
Variation of nicotinic binding sites among inbred strains
Marks, M. J., Romm, E., Campbell, S. M., & Collins, A. C. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90407-3 · Cited by 99
Effect of maternal nicotine on the development of sites for [3H]nicotine binding in the fetal brain
Hagino, N., & Lee, J. W. (1985) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(85)90046-2 · Cited by 98
Parikh, V., Kutlu, M. G., & Gould, T. J. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.020 · Cited by 106
“…anuscript family. α4β2 nAChRs possess high affinity for nicotine and have been shown to slowly desensitize and upregulate following continued nicotine exposure (Buisson and Bertrand, 2001; Fenster et al., 1999; Govind et al., 2009; Marks et al., 1983; Schwartz and Kellar, 1983; Yates et al., 1995).”
BackgroundMelis, M., Scheggi, S., Carta, G., Madeddu, C., Lecca, S., Luchicchi, A., Cadeddu, F., Frau, R., Fattore, L., Fadda, P., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4647-12.2013 · Cited by 101
“Particularly, given that relapse to nicotine is often related to stress and acute withdrawal, where functional upregulated 2*-nAChRs play a key role (Schwartz and Kellar, 1983; Marks et al., 1985), targeting PPAR might represent a promising therapeutic approach in nicotine relapse prevention and, ultimately, to help o…”
BackgroundNicotinic binding sites in cerebral cortex and hippocampus in alzheimer's dementia
London, E. D., Ball, M. J., & Waller, S. B. (1989) · Neurochemical Research · doi:10.1007/bf00964952 · Cited by 97
“The ligands [3H]ACh, (-)[3H]Nic, and [3H]methylcarbamylcholine have been useful for the characterization of central nicotinic cholinergic binding sites (20, 36, 37, 41, 43, 44).”
MethodGenetic and environmental risk factors in Parkinson’s disease
Veldman, B. A. J., Wijn, A. M., Knoers, N. V. A. M., Praamstra, P., & Horstink, M. W. I. M. (1998) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(98)00009-2 · Cited by 103
Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease
Kondo, I., & Yamamoto, M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00586-1 · Cited by 91
Long-term consequences of maternal smoking and developmental chronic nicotine exposure
Ursula, H. W.-S. (2007) · Frontiers in bioscience · doi:10.2741/2708 · Cited by 94
Mugnaini, M., Tessari, M., Tarter, G., Merlo Pich, E., Chiamulera, C., & Bunnemann, B. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02220.x · Cited by 88
“The discovery of nicotine-induced upregulation of nAChRs dates back to the 1980s and has been con®rmed by several authors (Marks et al., 1983; Schwartz & Kellar, 1983; Ksir et al., 1985; Benwell et al., 1988; Flores et al., 1992; Pauly et al., 1996; Breese et al., 1997; Rowell & Li, 1997; Perry et…”
BackgroundNordberg, A. K., Zhang, X. L., Fredriksson, A., & Eriksson, P. (1991) · Developmental Brain Research · doi:10.1016/0165-3806(91)90079-x · Cited by 93
Brazell, M. P., Mitchell, S. N., & Gray, J. A. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90116-s · Cited by 92
Nybäck, H., Nordberg, A. K., Långström, B., Halldin, C., Hartvig, P., Åhlin, A., Cg, S., & Sedvall, G. (1989) · Progress in brain research · doi:10.1016/s0079-6123(08)62490-5 · Cited by 96
NACHO Mediates Nicotinic Acetylcholine Receptor Function throughout the Brain
Matta, J. A., Gu, S., Davini, W. B., Lord, B., Siuda, E. R., Harrington, A. W., & Bredt, D. S. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.008 · Cited by 88
Tizabi, Y., Popke, E. J., Rahman, M. A., Nespor, S. M., & Grunberg, N. E. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00461-3 · Cited by 93
Rapid Upregulation of α7 Nicotinic Acetylcholine Receptors by Tyrosine Dephosphorylation
Cho, C.-H., Song, W., Leitzell, K., Teo, E., Meleth, A. D., Quick, M. W., & Lester, R. A. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.5389-03.2005 · Cited by 96
“The nature of such modifications are, at present, unknown; however, changes in the number and/or function of nicotinic acetylcholine receptors (nAChRs) that occurs during and after chronic nicotine treatment (Marks et al., 1983; Schwartz and Kellar, 1983) could lead to an alteration in synaptic transmission.”
BackgroundDevelopment of ligands for in vivo imaging of cerebral nicotinic receptors
Sihver, W., Nordberg, A. K., Långström, B., Mukhin, A. G., Koren, A. O., Kimes, A. S., & London, E. D. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00209-6 · Cited by 90
“Similar increases occur in brains of rodents chronically treated with nicotine [61,80,99].”
BackgroundAbdulla, F. A., Gray, J. A., Sinden, J. D., Bradbury, E. J., Calaminici, M., Lippiello, P. M., & Wonnacott, S. (1996) · Psychopharmacology · doi:10.1007/bf02247437 · Cited by 90
“By determining whether up-regulation in nicotine receptor binding, which may be expected to occur after chronic nicotine administration ( Schwartz and Kellar 1983; Lapchak et al. 1989; and see Wonnacott 1990), correlates with the enhanced performance in the water maze, we hoped to contribute to the debate (e.g., Ksir…”
Yin, R., & French, E. D. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00237-9 · Cited by 96
Pathophysiological Effects of Nicotine on the Pancreas: An Update
Chowdhury, P., Macleod, S. L., Udupa, K. B., & Rayford, P. L. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222700708 · Cited by 96
Nguyen, H. N., Rasmussen, B. A., & Perry, D. C. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02482.x · Cited by 83
Persistence of chronic nicotine-induced cognitive facilitation
Levin, E. D., Briggs, S. J., Christopher, N. C., & Rose, J. E. (1992) · Behavioral and Neural Biology · doi:10.1016/0163-1047(92)90399-o · Cited by 90
Metadata
- Authors
- Schwartz, R. D., & Kellar, K. J.
- Affiliations
- Georgetown University (US)
- ORCID
- Kellar, Kenneth J.
- Venue
- Science
- Published
- 1983-04-08
- Volume
- 220
- Issue
- 4593
- Pages
- 214-216
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2091374932
- Cited by
- 479
- References
- 17
- Citations by year
- 2025: 1 · 2024: 7 · 2023: 6 · 2022: 8 · 2021: 3 · 2020: 14 · 2019: 2 · 2018: 5 · 2017: 5 · 2016: 11 · 2015: 12 · 2014: 13 · 2013: 17 · 2012: 19
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, receptor binding sites, diisopropylfluorophosphate, nicotine, cholinesterase inhibition, cerebral cortex, receptor regulation, receptor density, receptor binding affinity, saturation analysis
- MeSH terms
- Acetylcholine, Animals, Brain, Brain Chemistry, Cerebral Cortex, Isoflurophate, Male, Nicotine, Rats, Inbred Strains, Receptors, Cholinergic, Receptors, Nicotinic, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.